BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2007
View Archived Issues
New pharmacokinetic data on iloperidone available
Read More
Respiratory tract-delivered vaccine confers protection against Ebola virus infection in monkeys
Read More
Takeda terminates development of fixed dose Actos + TAK-536 product
Read More
AtheroGenics to focus on diabetes for AGI-1067
Read More
FDA outlines data requirements for Provenge BLA approval
Read More
Treatment completed in prophylactic phase III trial of C1-INH for HAE
Read More
Venticute awarded fast track designation
Read More
Positive topline phase Ib findings for bavituximab in advanced cancers
Read More
Amgen to acquire Ilypsa
Read More
BNC-105 shows preclinical efficacy in prostate tumors
Read More
MF-101 reduces frequency and severity of postmenopausal hot flashes
Read More
Coronado licenses rights from Burnham to develop and commercialize Apogossypol
Read More
NIAID grant supports work on fungal antigens in chronic sinusitis
Read More
R&D highlights from BIO 2007 in Boston: Zealand Pharma
Read More
R&D highlights from BIO 2007 in Boston: BioInvent International
Read More
New vascular-targeting agent moves forward to phase II trials based on positive phase I findings
Read More
Encouraging findings emerge from first-in-man trial of peptibody AMG-386
Read More
First-in-human study of a potent pan-HER tyrosine kinase inhibitor from Pfizer
Read More
Positive results for DNA vaccine adjuvant Vaxfectin in nonhuman primates
Read More
Phase I study suggests promise for orally active VEGFR/FGFR tyrosine kinase inhibitor
Read More
CX-3543, Cylene's lead rDNA biogenesis inhibitor, discussed at ASCO
Read More
Audit to be performed on phase III trial results of PreHistin
Read More
BAY-73-4506, a multikinase inhibitor, active and well tolerated in advanced cancer
Read More
Valeant's retigabine moves towards phase II study in PHN
Read More
Recent sanofi-aventis and Kumamoto University patents impart new agents for autoimmune diseases
Read More
Priority review for Abilify in pediatric schizophrenia
Read More
Biovest to seek conditional approval of BiovaxID
Read More
Novel diagnostic agents reported in recent GE Healthcare patent
Read More
Divigel approved to treat menopausal hot flashes
Read More
Recent Helperby and 3M patents disclose new antiinfective agents
Read More
